Key Takeaways:New launches in the femtech industry are focusing on PCOS care.These condition-centric products show a shift from treating symptoms to addressing the root cause. PCOS care presents opportunities for cross-industry collaborations with beauty and wellness sectors.As women’s health awareness shifts from a moment to a mainstream movement, a new generation of femtech brands is redefining care for those living with hormonal conditions like polycystic ovary syndrome (PCOS). This chronic endocrinopathy affects women, trans men, and nonbinary people, impacting their metabolic, physiological, and psychological health—not just reproductive function. Yet after decades of being underdiagnosed and underresearched, many are still left struggling in silence.Medical misogyny led to decades of misinformation and misdiagnosis: PCOS affects 6%-13% of people with vulvas globally, yet up to 70% of cases go undiagnosed (and 64% of sufferers experience depressive disorders).In fact, research released in July discovered that people with the condition are also more likely to have alexithymia and a higher cyclothymic temperament—a predisposition to periods of mild depression and hypomania—while another study highlighted how sufferers are more prone to eating disorders.With diagnosis often taking up to ten years, other studies have focused on identifiers: In August, researchers announced how they are using machine learning to identify data-driven PCOS subtypes—highlighting how more precise diagnosis and management strategies tailored to individual profiles are on the horizon.Data also shows that the North American PCOS treatment market was valued at $4.